The NIH starts spending $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) projects

___ NIH Starts to Spend $4.8 Billion in “Extra” Cures Drug Research Money (P&T Community): “The National Institutes of Health (NIH) launched 110 new brain research projects in the fiscal year ending last September (2017) with the first portion of the $1.5 billion over 10 years it will hopefully receive from the 21st Century Cures Act, which spread a total of $4.8 billion over four NIH programs. That is money over and above the NIH annual appropriation from Congress. The other three “Innovation Funds” are: Precision Medicine, Cancer Moonshot, and Regenerative Medicine. The $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) research money seems particularly important given the announcement in January that Pfizer was ending its Alzheimer’s research program after years of fruitless development efforts, which have plagued other companies as well…A prime example is the “All of Us” initiative, which is the primary focus of the Precision Medicine Initiative (PMI). While the FDA is using Cures money to aggregate patient post-marketing data, the NIH will be collecting patient data in order to learn about medical conditions and to assemble a critical mass of potential clinical trial participants. The NIH is partnering with five companies to create a participant technology center. “Getting all these partners on board would have been nearly impossible had not the Cures Act included something called Other Transactions Authorit...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology Alzheimers brain clinical-trials Innovation Funds Moonshot National-Institutes-of-Health Neuro-technologies neurotechnologies NIH Pfizer Source Type: blogs